EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Antiseizure Medication Dispensing Before and After Initiation of Antidementia Medicines: A Population‐Based Matched Cohort Study

Osvaldo P. Almeida, Christopher Etherton‐Beer, Frank M. Sanfilippo, David B. Preen, Amy Page

Pharmacoepidemiology and Drug Safety · 2026-11 · 35 (11)

DOI: 10.1002/pds.70530 ↗
AbstractBibliografische Angaben

Abstract

ABSTRACT Purpose Seizures and behavioural and psychiatric features may prompt antiseizure medication (ASM) use in dementia. We examined whether increased ASM dispensing precedes or follows initiation of antidementia treatment to inform hypotheses about when these indications emerge. Methods Using the Australian Pharmaceutical Benefits Scheme (PBS) 10% sample, we matched people aged ≥ 50 years with incident antidementia dispensing in 2018–2021 1:1 to controls without antidementia dispensing (2013–2024) by age, sex, index year and diabetes and hypertension treatment. We compared annual ASM dispensing (ATC N03, excluding gabapentinoids) from 5 years before to 3 years after initiation using McNemar's test and interrupted time series analysis. Sensitivity analyses re‐matched on Rx‐Risk comorbidity and removed the survival requirement. Results Among 4385 matched pairs (59.8% women; mean age 78.3 years), ASM dispensing was higher in cases 5 years before initiation (2.7% vs. 1.8%; ratio 1.53, 95% CI = 1.15–2.03) and the difference widened after initiation (year 3: 9.1% vs. 2.4%; ratio 3.85, 95% CI = 3.13–4.75). Valproate accounted for most of the excess (year 3 ratio 6.97, 95% CI = 4.80–10.12). Levetiracetam dispensing rose gradually from year −3 and was higher after initiation (year 3 ratio 2.30, 95% CI = 1.51–3.50). Matching on comorbidity attenuated pre‐initiation differences (year −5 ratio 1.42). The excess was greater at ages 50–79 years. Conclusions ASM dispensing, most noticeably valproate, was higher in people with antidementia medicine dispensing than in controls, modestly before and markedly after initiation. Behavioural and psychiatric indications seem to predominate, with a smaller seizure‐related contribution possibly beginning before treatment, although dispensing data cannot confirm indications. Valproate use warrants review.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →